HIV / AIDS in the News

Merck’s New HIV Drug And Mixed Oncology Data Reframe Growth Story - simplywall.st

 

Merck (MRK) Receives FDA Approval for Idvynso, a New HIV Treatme - GuruFocus

 

Wanted: new writers for aidsmap - European AIDS Treatment Group

 

Merck Weighs New HIV Approval Against Mixed Oncology Trial Results - Yahoo Finance

 

Ethical considerations and incentives in biomedical HIV research - Inside UCR

 

The Telegraph: One-in-three Russians should be tested for HIV every year, urges health minister - European AIDS Treatment Group

 

FDA Approves Doravirine/Islatravir as Treatment for HIV - Drug Topics

 

Expert quits US HIV role, rebukes Trump global health approach - The Straits Times

 

Expert quits US HIV role, rebukes Trump's global health approach - Reuters

 

U.S. HIV/AIDS Chief Science Officer Resigns, Criticizes Aid Policy - Devdiscourse

 

Expert quits US HIV role, rebukes Trump global health approach - TradingView

 

[Press release] U.S. Department of State: PEPFAR data release - European AIDS Treatment Group

 

Opinion: Medicaid-Funded Care Saves and Rebuilds Lives - citylimits.org

 

FDA Approves New Standalone Combo Pill for HIV - MedPage Today

 

HIV cases on the rise in Chicago: Doctor offers insight on how to slow the trend - WGN-TV

 

HIV cases on the rise in Chicago: Doctor offers insight on how to slow the trend - WGN-TV

 

ACTG launches critical study evaluating hormone therapy for women living with HIV in the menopause transition - European AIDS Treatment Group

 

FDA Approves Doravirine/Islatravir, a First-in-Class Two-Drug HIV Regimen - Contagion Live

 

HIV cases on the rise in Chicago: Doctor offers insight on how to slow the trend - WGN-TV

 

Religious Exemption Laws Are Leading to Drops in HIV Testing - U.S. News & World Report

 

Survivors: Portraits of Resilience Personal Accounts of the AIDS Crisis - Artlyst

 

National HIV advocacy group's CEO rejects claims of crisis - Advocate.com

 

'12,000 Floridians cannot wait': New campaign demands permanent funding fix for HIV drug program - WLRN

 

Our anti-HIV jab will be rolled out in 6 weeks. But funding cuts hollowed out the system needed to deliver it - Bhekisisa

 

For Young People, Now’s the Time to Talk About HIV - Word In Black

 

Radio campaign on preventing mother-to-child HIV transmission set for launch - The Nation Newspaper

 

Recon: FDA approves Merck’s HIV pill combo; Moderna gets EU nod for combined flu, COVID shot in older patients - RAPS.org

 

Florida International University: HIV disrupts lung "clock," raising COPD and emphysema risk - European AIDS Treatment Group

 

University of Gothenburg: Early immune responses linked to protective HIV antibodies - European AIDS Treatment Group

 

US FDA approves Merck's pill combo to treat HIV infection - Reuters